Shots: 2023 had been a great year for the biopharma industry despite several imposed restrictions from the IRA and inflation With several swaying factors impacting the biopharma industry, including social, economic, regulatory and others, some of the noteworthy trends that emerged in 2024 and are shaping the ways biopharma companies operate The article explores four key…